Morning-after pill creates controversy.
D000019:Abortifacient Agents; D000028:Abortion, Induced; D003282:Contraceptives, Postcoital, Hormonal; D010064:Embryo Implantation / Q000187:drug effects*; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D005602:France; D006801:Humans; D015735:Mifepristone / Q000494:pharmacology*; D009644:Norgestrel / Q000494:pharmacology*; D011247:Pregnancy; D014481:United States
D000019:Abortifacient Agents; D003282:Contraceptives, Postcoital, Hormonal; D015735:Mifepristone; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination